Skip to content

Home
Columns
- Overcoming Adversity
News Categories
About Lymphoma
Lymphoma Drugs
- Approved Treatments
  - Rituxan (Rituximab)
  - Aliqopa (Copanlisib)
- Experimental Treatments

Search for:

5 Minutes to Change the Life of a Woman in Need

May 4, 2016June 17, 2016

In Social Clips.

In this WCPO.com | 9 On Your Side video, learn more about how a local man saved a life by joining a bone marrow registry.

Learn more about lymphoma here: http://bit.ly/1UwWKe6

Print Friendly, PDF & Email

Print This Page

Tagged Delete Blood Cancer.

admin

Post navigation

Previous: 4 Tests to Diagnose Lymphoma

Next:Compound Effectively Targets Mutated Protein in B-Cell Lymphoma and Melanoma Early Study

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Search for:

Recent Posts

Opdivo Plus ASCT Ably Treats Classical Hodgkin’s Lymphoma Patients with Few Options, Study Says

November 16, 2018
Verastem Advances Copiktra for Peripheral T-cell Lymphoma Under LLS Therapy Acceleration Program

November 14, 2018
Rituxan Shows Similar Benefit With or Without Chemo in Indolent Lymphomas, Study Finds

November 13, 2018
FDA Gives Selinexor Fast Track Status for DLBCL Treatment

November 12, 2018
Seattle Genetics Seeks Adcetris Approval as First-Line Combo Treatment for Peripheral T-cell Lymphomas

November 9, 2018
Adcetris as Stem Cell Transplant Consolidation Therapy Delays Hodgkin’s Progression in Long-term, Data Show

November 6, 2018
Imbruvica Combo Improves Long-term Survival in CLL/SLL Patients, Updated Phase 3 Results Show

November 5, 2018
MK-1454/Keytruda Combination Shows Promise in Solid Tumor and Lymphoma Patients

November 5, 2018
I Find Hope in Cancer-themed Humor

November 2, 2018
BeiGene Asking That Zanubrutinib Be Approved to Treat Advanced CLL/SLL Patients in China

October 31, 2018
BTK Inhibitor M7583 Shows Significant Benefit in B-Cell Lymphomas in Phase 1 Trial

October 30, 2018
Targeting B-cell Lymphoma with Natural Killer T-cells May Be More Effective, Cheaper, Preclinical Study Shows

October 29, 2018

Featured Posts

Hope Matters As I Celebrate My 10-Year ‘Diagnosiversary’

August 10, 2018

Nearly Half of NHL Patients in Phase 1 Trial Respond to ALT-803, Rituxan Combo, Results Show

April 26, 2018

Takeda, Nectar Plan to Test New IO Combination in non-Hodgkin Lymphoma Patients

May 4, 2018

Visit Lymphoma News Today's profile on Pinterest.

Lymphoma News Today

BioNews Services, LLC
3 W. Garden St.
Suite 354
Pensacola, FL 32502
Email: [email protected]
Phone: 1-800-936-1363

About Us
Contact Us
Terms of Service
Privacy Policy

Disclaimer:

Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2018 Copyright 2015 © All rights reserved

Pin It on Pinterest

Share This

Facebook
Twitter
Google+
Pinterest
LinkedIn

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. Ok Read more